Oncogenic Transformation by Basic Fibroblast Growth Factor
Several years ago Sporn and Todaro proposed autocrine growth stimulation as a mechanism for cellular transformation (Sporn and Todaro, 1980). According to this model, continuous proliferation occurs in a cell that possesses the cognate receptor for a growth factor that the cell secretes, (Long et al., 1985; Rosenthal et al., 1986; Finzi et al., 1987; Watanabe et al., 1987). This has been shown to be the cause of oncogenic conversion by numerous growth factors, including sis, epidermal growth factor (EGF), CSF-1, GM-CSF, and transforming growth factor α (TGF α) (Doolittle et al., 1983; Rosenthal et al., 1986; Stern et al., 1987; Waterfield et al., 1983; Wheeler et al., 1986).
KeywordsSignal Peptide Long Terminal Repeat Basic Fibroblast Growth Factor Bovine Aortic Endothelial Cell Type Alpha
Unable to display preview. Download preview PDF.
- Kurokawa, M., Doctrow, S. and Klagsbrun, M. 1989. Neutralizing antibodies inhibit binding of bFGF to its receptor but not to heparin. J. Biol. Chem., In press.Google Scholar
- Waterfield, M.D., Scarce, G.T., Whittle, N., Stroobert, P., Johnsson, A., Wasteson, A., Westermark, B., Heldin, C-H., Huang, J.S. and Deuel, T.F. 1983. Platelet-derived growth factor is structurally related to the putative transforming protein of Simian sarcoma virus. Nature (London), 304:35CrossRefGoogle Scholar